Molecular characteristics of non-small cell lung cancer (NSCLC) patients sensitive to gefitinib

7025 Background: Gefitinib (Iressa), a small molecule inhibitor of the epidermal growth factor receptor tyrosine kinase (EGFR-TK), induces objective regressions in 9–18% of NSCLC patients. Bronchio...